Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancerJuly 30, 2026
General Researchers train AI to detect diabetes and assign four diagnostic labelsBy Healthcare Propulsion StaffJuly 29, 20260 A two-stage AI framework showed strong internal performance across four diabetes-related groups, but its reliance on separate public datasets leaves…